Hangzhou Minsheng Healthcare Co (301507) Fair Value & Analysis

Healthcare · CN · Market cap 4.4B CNY

Analysis

Hangzhou Minsheng Healthcare Co (301507) currently trades at ¥12.41, while our model-based Fair Value estimate is ¥5.48 — implying the stock looks roughly 55.8% overvalued today. We read business quality at 86/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Hangzhou Minsheng Healthcare Co., Ltd. engages in the research, development, production, and sale of vitamins and mineral supplements, OTC drugs, and health foods in China. The company offers healthy products, such as fish and algae oil gel candy, collagen peptide vitamin D calcium chewable tablets, blueberry lutein ester candy tablets, and probiotic solid beverage. It also provides multivitamin, vitamin, and zinc selenium with mineral tablets; and glucosamine chondroitin colostrum protein chewable, vitamin soft capsules and chewable, iron folic acid, melatonin, coenzyme soft capsules, and calcium magnesium vitamin D tablets. The company offers its product under the 21 SUPER-VITA brand name. Hangzhou Minsheng Healthcare Co., Ltd. was founded in 1926 and is based in Hangzhou, China.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.